| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |